Search Results - "CASANOVAS, Oriol"

Refine Results
  1. 1

    Unraveling the Role of Angiogenesis in Cancer Ecosystems by Zuazo-Gaztelu, Iratxe, Casanovas, Oriol

    Published in Frontiers in oncology (02-07-2018)
    “…Activation of the tumor and stromal cell-driven angiogenic program is one of the first requirements in the tumor ecosystem for growth and dissemination. The…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis by Pàez-Ribes, Marta, Allen, Elizabeth, Hudock, James, Takeda, Takaaki, Okuyama, Hiroaki, Viñals, Francesc, Inoue, Masahiro, Bergers, Gabriele, Hanahan, Douglas, Casanovas, Oriol

    Published in Cancer cell (03-03-2009)
    “…Multiple angiogenesis inhibitors have been therapeutically validated in preclinical cancer models, and several in clinical trials. Here we report that…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors by Casanovas, Oriol, Hicklin, Daniel J., Bergers, Gabriele, Hanahan, Douglas

    Published in Cancer cell (01-10-2005)
    “…Function-blocking antibodies to VEGF receptors R1 and R2 were used to probe their roles in controlling angiogenesis in a mouse model of pancreatic islet…”
    Get full text
    Journal Article
  8. 8

    Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice by Maione, Federica, Capano, Stefania, Regano, Donatella, Zentilin, Lorena, Giacca, Mauro, Casanovas, Oriol, Bussolino, Federico, Serini, Guido, Giraudo, Enrico

    Published in The Journal of clinical investigation (01-05-2012)
    “…Cancer development, progression, and metastasis are highly dependent on angiogenesis. The use of antiangiogenic drugs has been proposed as a novel strategy to…”
    Get full text
    Journal Article
  9. 9

    The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels by Alsina‐Sanchis, Elisenda, Figueras, Agnès, Lahiguera, Álvaro, Vidal, August, Casanovas, Oriol, Graupera, Mariona, Villanueva, Alberto, Viñals, Francesc

    Published in International journal of cancer (15-10-2016)
    “…In a search for new therapeutic targets for treating epithelial ovarian cancer, we analyzed the Transforming Growth Factor Beta (TGFβ) signaling pathway in…”
    Get full text
    Journal Article
  10. 10

    Incidence of diabetes mellitus and associated risk factors in the adult population of the Basque country, Spain by Urrutia, Inés, Martín-Nieto, Alicia, Martínez, Rosa, Casanovas-Marsal, J Oriol, Aguayo, Anibal, del Olmo, Juan, Arana, Eunate, Fernandez-Rubio, Elsa, Castaño, Luis, Gaztambide, Sonia

    Published in Scientific reports (04-02-2021)
    “…The aim of this study was to estimate the incidence of diabetes mellitus in the Basque Country and the risk factors involved in the disease by reassessing an…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents by Zuazo-Gaztelu, Iratxe, Pàez-Ribes, Marta, Carrasco, Patricia, Martín, Laura, Soler, Adriana, Martínez-Lozano, Mar, Pons, Roser, Llena, Judith, Palomero, Luis, Graupera, Mariona, Casanovas, Oriol

    Published in Cancer research (Chicago, Ill.) (15-10-2019)
    “…One of the main consequences of inhibition of neovessel growth and vessel pruning produced by angiogenesis inhibitors is increased intratumor hypoxia. Growing…”
    Get full text
    Journal Article
  13. 13

    Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors by Soler, Adriana, Figueiredo, Ana M, Castel, Pau, Martin, Laura, Monelli, Erika, Angulo-Urarte, Ana, Milà-Guasch, Maria, Viñals, Francesc, Baselga, Jose, Casanovas, Oriol, Graupera, Mariona

    Published in Clinical cancer research (01-12-2016)
    “…Mutations in the PI3K pathway occur in 16% of patients with pancreatic neuroendocrine tumors (PanNETs), which suggests that these tumors are an exciting…”
    Get full text
    Journal Article
  14. 14

    Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis by Soler, Adriana, Serra, Helena, Pearce, Wayne, Angulo, Ana, Guillermet-Guibert, Julie, Friedman, Lori S, Viñals, Francesc, Gerhardt, Holger, Casanovas, Oriol, Graupera, Mariona, Vanhaesebroeck, Bart

    Published in The Journal of experimental medicine (23-09-2013)
    “…Understanding the direct, tumor cell-intrinsic effects of PI 3-kinase (PI3K) has been a key focus of research to date. Here, we report that cancer…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination by Figueras, Agnès, Alsina-Sanchís, Elisenda, Lahiguera, Álvaro, Abreu, Manuel, Muinelo-Romay, Laura, Moreno-Bueno, Gema, Casanovas, Oriol, Graupera, Mariona, Matias-Guiu, Xavier, Vidal, August, Villanueva, Alberto, Viñals, Francesc

    Published in Molecular cancer therapeutics (01-02-2018)
    “…Epithelial ovarian cancer is characterized by a low recovery rate because the disease is typically diagnosed at an advanced stage, by which time most patients…”
    Get full text
    Journal Article
  18. 18

    Antiangiogenic Resistance: Novel Angiogenesis Axes Uncovered by Antiangiogenic Therapies Research by Jiménez-Valerio, Gabriela, Casanovas, Oriol

    Published in Current drug targets (01-01-2016)
    “…The mechanisms of tumor growth and progression involve the activation of different processes such as neovascularization and angiogenesis. These processes…”
    Get more information
    Journal Article
  19. 19
  20. 20